| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV
|
Bollinger, Robert C
|
|
|
7 |
6 |
p. e443-e448
|
artikel
|
| 2 |
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17–22)
|
Stephenson, Kathryn E
|
|
|
7 |
6 |
p. e410-e421
|
artikel
|
| 3 |
Conceptualising implementation strategies in HIV research
|
Mody, Aaloke
|
|
|
7 |
6 |
p. e382
|
artikel
|
| 4 |
Conceptualising implementation strategies in HIV research – Authors' reply
|
Drain, Paul K
|
|
|
7 |
6 |
p. e382-e383
|
artikel
|
| 5 |
COVID-19 in patients with HIV
|
Jones, Rachael
|
|
|
7 |
6 |
p. e383
|
artikel
|
| 6 |
COVID-19 in patients with HIV – Authors' reply
|
Miró, José M
|
|
|
7 |
6 |
p. e383-e384
|
artikel
|
| 7 |
Evolving ART crisis for people living with HIV in Indonesia
|
Luis, Hendry
|
|
|
7 |
6 |
p. e384-e385
|
artikel
|
| 8 |
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials
|
Orkin, Chloe
|
|
|
7 |
6 |
p. e389-e400
|
artikel
|
| 9 |
HIV outbreaks among people who inject drugs in Europe, North America, and Israel
|
Des Jarlais, Don C
|
|
|
7 |
6 |
p. e434-e442
|
artikel
|
| 10 |
HIV service delivery innovation in high-prevalence settings
|
Ortblad, Katrina F
|
|
|
7 |
6 |
p. e378-e379
|
artikel
|
| 11 |
Justice for victims of forced sterilisation
|
Ligami, Christabel
|
|
|
7 |
6 |
p. e386-e387
|
artikel
|
| 12 |
KELIN: defending human rights of people with HIV in Kenya
|
Ligami, Christabel
|
|
|
7 |
6 |
p. e388
|
artikel
|
| 13 |
Lockdown fears for key populations
|
The Lancet HIV,
|
|
|
7 |
6 |
p. e373
|
artikel
|
| 14 |
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
|
Dooley, Kelly E
|
|
|
7 |
6 |
p. e401-e409
|
artikel
|
| 15 |
Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial
|
Wirth, Kathleen E
|
|
|
7 |
6 |
p. e422-e433
|
artikel
|
| 16 |
Prevention of tuberculosis in HIV infection with novel drugs
|
Mayanja-Kizza, Harriet
|
|
|
7 |
6 |
p. e375-e376
|
artikel
|
| 17 |
Responding to expanding HIV epidemics in Cebu, Philippines
|
Medland, Nicholas A
|
|
|
7 |
6 |
p. e380-e381
|
artikel
|
| 18 |
Shortening HIV vaccine regimens to achieve high coverage
|
Blasi, Maria
|
|
|
7 |
6 |
p. e377-e378
|
artikel
|
| 19 |
Weighing considerations with newer antiretrovirals
|
Venter, W D Francois
|
|
|
7 |
6 |
p. e374-e375
|
artikel
|
Tijdschrift beschrijving